(Q35036493)

5 August 2017

1 reference

title

Sex and gender considerations in male patients with osteoporosis (English)

1 reference

5 August 2017

0 references

Christopher J Dy

1

1 reference

5 August 2017

Lauren E Lamont

series ordinal

2

1 reference

5 August 2017

Quang V Ton

series ordinal

3

1 reference

5 August 2017

Joseph M Lane

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

Clinical Orthopaedics and Related Research

5 August 2017

published in

1 reference

5 August 2017

volume

469

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

1906-1912

1 reference

https://scigraph.springernature.com/pub.10.1007/s11999-011-1849-3

5 August 2017

exact match

0 references

cites work

Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

8 July 2018

Physiology of bone loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Approach to the patient with secondary osteoporosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Influence of intramedullary nail diameter and locking mode on the stability of tibial shaft fracture fixation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Low-energy femoral shaft fractures associated with alendronate use.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Clinical practice. Osteoporosis in men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), an

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Sexual dimorphism of body composition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Patterns of bone mineral density testing: current guidelines, testing rates, and interventions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Treatment of male osteoporosis: recent advances with alendronate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Mortality, morbidity, and assessment of fracture risk in male osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Clinical review 137: Sexual dimorphism in skeletal size, density, and strength

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Estrogen replacement therapy and the surgeon

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Esophagitis associated with the use of alendronate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Risk factors for osteoporotic fractures in elderly men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Osteoporosis awareness protocol for patients with fragility fractures

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Effects of estrogen on fracture healing in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Secondary contributors to bone loss in osteoporosis related hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

The near absence of osteoporosis treatment in older men with fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Bone health in men: influencing factors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111783

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

25 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11999-011-1849-3

Vitamin D and intact PTH status in patients with hip fracture

21 January 2018

1 reference

12 December 2020

Osteoporosis. Information from your family doctor

1 reference

12 December 2020

Osteoporosis in males and females: Is there really a difference?

1 reference

12 December 2020

Exploring the biological contributions to human health: does sex matter?

1 reference

12 December 2020

Undertreatment of osteoporosis in men with hip fracture

1 reference

12 December 2020

Incidence of Hip and Other Osteoporotic Fractures in Elderly Men and Women: Dubbo Osteoporosis Epidemiology Study

1 reference

12 December 2020

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Does Sex Matter in Musculoskeletal Health? The Influence of Sex and Gender on Musculoskeletal Health *

1 reference

12 December 2020

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

1 reference

12 December 2020

10.1007/S11999-011-1849-3

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference